SNDX SYNDAX PHARMACEUTICALS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 10 analyst firms say about SYNDAX PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 6 months
Analyst view · last 6M
9 rated views · 10 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MGood · #27 in the index89
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8060
Recent analyst activity · last 90 days
Our tracked history has 9 reports on SNDX from 6 analyst firms in the last 90 days (16 firms in the past year).
Comparing each firm's latest target with its previous one: 3 lowered it and 2 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: HC Wainwright lowered its target from $38.00 (set 13 Oct 2026) to $36.00 on 3 Nov 2026.
Last 6 months. Latest opinion per identifiable analyst within the last 6 months. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Mayank Mamtani | Buy | 14 May 2026 | 33.00 USD |
| Bank of America Securities | Unnamed analyst | Buy | 5 Aug 2026 | — |
| Barclays | Etzer Darout | Buy | 13 Oct 2026 | 37.00 USD |
| H.C. Wainwright | Andres Y. Maldonado | Buy | 13 Oct 2026 | 38.00 USD |
| Jefferies | Faisal Khurshid | Buy | 29 Sep 2026 | 35.00 USD |
| JPMorgan | Anupam Rama | Buy | 11 Aug 2026 | 40.00 USD |
| TD Cowen | Philip M Nadeau | Buy | 15 Jun 2026 | — |
| UBS | David Dai | Buy | 1 Oct 2026 | 33.00 USD · 21 Aug 2026 |
| Weiss Ratings | Unnamed analyst | — | 19 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:55 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.